Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2014 Q1- Text added to 2014 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
New words:
advantage, arm, ASU, baseline, carcinoma, cluster, CRP, diffuse, emerging, gathered, Genentech, head, Japan, MedImmune, neck, nivolumab, pembrolizumab, proactively, proportion, protein, rare, Squibb, stable, symptom, tamoxifen, toxicological, underpowering, underway, week
Removed:
allege, equitable, evaluated, purported, qualify, qualifying, unspecified
Valuein 2014 Q1 filing- Value in 2014 Q2 filing
Original filings
Filing view